Ketamine-Assisted Psychotherapy for Treatment of Co-occurring Borderline Personality Disorder and Depression: A Case Study

被引:0
作者
Yeung, Albert [1 ]
Alpert, Michael [2 ]
Mischoulon, David [1 ]
机构
[1] Massachusetts Gen Hosp, Depress Clin & Res Program, Boston, MA USA
[2] Beth Israel Deaconess Med Ctr, Dept Psychiat, Boston, MA USA
关键词
ketamine-assisted psychotherapy; treatment; borderline personality disorder; major depressive disorder; psychedelic-assisted psychotherapy; PSILOCYBIN; EFFICACY; ANXIETY; SAFETY;
D O I
10.1521/pedi.2025.39.2.170
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Borderline personality disorder (BPD) is a mental health condition characterized by a pervasive pattern of impulsivity, affective dysregulation, and cognitive-perceptual symptoms. Treatment of BPD remains a significant challenge to mental health clinicians. People who suffer from BPD frequently have comorbid psychiatric disorders, which makes treatment more complex. This case study describes a course of ketamine-assisted psychotherapy (KAP) to treat a patient with co-occurring BPD and depression. KAP uses the antidepressant and psychedelic effects of ketamine embedded in a psychotherapy format to utilize the concept of an inner healing intelligence within the patient and the intersubjective relationship between patient and therapist as therapeutic factors. The positive outcomes in this case study suggest that more systematic research is warranted in the use of KAP for treatment of BPD and other personality disorders.
引用
收藏
页码:170 / 184
页数:15
相关论文
共 37 条
[1]   Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer [J].
Agin-Liebes, Gabrielle, I ;
Malone, Tara ;
Yalch, Matthew M. ;
Mennenga, Sarah E. ;
Ponte, K. Linnae ;
Guss, Jeffrey ;
Bossis, Anthony P. ;
Grigsby, Jim ;
Fischer, Stacy ;
Ross, Stephen .
JOURNAL OF PSYCHOPHARMACOLOGY, 2020, 34 (02) :155-166
[2]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[3]   Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder A Randomized Clinical Trial [J].
Bogenschutz, Michael P. ;
Ross, Stephen ;
Bhatt, Snehal ;
Baron, Tara ;
Forcehimes, Alyssa A. ;
Laska, Eugene ;
Mennenga, Sarah E. ;
O'Donnell, Kelley ;
Owens, Lindsey T. ;
Podrebarac, Samantha ;
Rotrosen, John ;
Tonigan, J. Scott ;
Worth, Lindsay .
JAMA PSYCHIATRY, 2022, 79 (10) :953-962
[4]   Classic hallucinogens in the treatment of addictions [J].
Bogenschutz, Michael P. ;
Johnson, Matthew W. .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 64 :250-258
[5]   REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics [J].
Carhart-Harris, R. L. ;
Friston, K. J. .
PHARMACOLOGICAL REVIEWS, 2019, 71 (03) :316-344
[6]   How do psychedelics work? [J].
Carhart-Harris, Robin L. .
CURRENT OPINION IN PSYCHIATRY, 2019, 32 (01) :16-21
[7]  
Chapman J, 2023, StatPearls
[8]   The use of ketamine as an antidepressant: a systematic review and meta-analysis [J].
Coyle, Caoimhe M. ;
Laws, Keith R. .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2015, 30 (03) :152-163
[9]   Efficacy of Psychotherapies for Borderline Personality Disorder A Systematic Review and Meta-analysis [J].
Cristea, Ioana A. ;
Gentili, Claudio ;
Cotet, Carmen D. ;
Palomba, Daniela ;
Barbui, Corrado ;
Cuijpers, Pim .
JAMA PSYCHIATRY, 2017, 74 (04) :319-328
[10]   Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder [J].
Danayan, Kevork ;
Chisamore, Noah ;
Rodrigues, Nelson B. ;
Di Vincenzo, Joshua D. ;
Meshkat, Shakila ;
Doyle, Zoe ;
Mansur, Rodrigo ;
Phan, Lee ;
Fancy, Farhan ;
Chau, Edmond ;
Tabassum, Aniqa ;
Kratiuk, Kevin ;
Arekapudi, Anil ;
Teopiz, Kayla M. ;
McIntyre, Roger S. ;
Rosenblat, Joshua D. .
PSYCHIATRY RESEARCH, 2023, 323